Works matching AU Ji, Linong
Results: 386
Effect of Hemoglobin A1c Reduction or Weight Reduction on Blood Pressure in Glucagon-Like Peptide-1 Receptor Agonist and Sodium-Glucose Cotransporter-2 Inhibitor Treatment in Type 2 Diabetes Mellitus: A Meta-Analysis.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Comparison of the dietary intakes of individuals with and without type 1 diabetes in China.
- Published in:
- 2015
- By:
- Publication type:
- journal article
Validation of the Swedish Diabetes Re-Grouping Scheme in Adult-Onset Diabetes in China.
- Published in:
- 2020
- By:
- Publication type:
- journal article
ADA/EASD Precision Medicine in Diabetes Initiative: An International Perspective and Future Vision for Precision Medicine in Diabetes.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Characteristics and Ongoing Autoimmunity of Patients With Long-standing Type 1 Diabetes Living in China.
- Published in:
- 2018
- By:
- Publication type:
- Letter
Metabolic Surgery in the Treatment Algorithm for Type 2 Diabetes: A Joint Statement by International Diabetes Organizations.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Exon Sequencing of HNF1β in Chinese Patients with Early-Onset Diabetes.
- Published in:
- Diabetes & Metabolism Journal, 2025, v. 49, n. 2, p. 321, doi. 10.4093/dmj.2024.0159
- By:
- Publication type:
- Article
Proprotein Convertase Subtilisin/Kexin Type 9 Inhibitors and the Risk of Fracture: A Systematic Review and Meta-analysis of Randomized Controlled Trials.
- Published in:
- Calcified Tissue International, 2023, v. 113, n. 2, p. 175, doi. 10.1007/s00223-023-01085-0
- By:
- Publication type:
- Article
An Update on Animal Models of Osteogenesis Imperfecta.
- Published in:
- Calcified Tissue International, 2022, v. 111, n. 4, p. 345, doi. 10.1007/s00223-022-00998-6
- By:
- Publication type:
- Article
Factors Associated with Acute Complications among Individuals with Type 1 Diabetes in China: The 3C Study.
- Published in:
- Endocrine Research, 2020, v. 45, n. 1, p. 1, doi. 10.1080/07435800.2019.1624567
- By:
- Publication type:
- Article
Impact of variants of the EXT2 gene on Type 2 diabetes and its related traits in the Chinese han population.
- Published in:
- Endocrine Research, 2015, v. 40, n. 2, p. 79, doi. 10.3109/07435800.2014.952015
- By:
- Publication type:
- Article
Review: Machine learning in precision pharmacotherapy of type 2 diabetes—A promising future or a glimpse of hope?
- Published in:
- Digital Health, 2023, p. 1, doi. 10.1177/20552076231203879
- By:
- Publication type:
- Article
The characteristics of newly diagnosed adult early-onset diabetes: a population-based cross-sectional study.
- Published in:
- Scientific Reports, 2017, p. 46534, doi. 10.1038/srep46534
- By:
- Publication type:
- Article
Real‐world usage of sulphonylureas in Asian patients with type 2 diabetes using the Joint Asia Diabetes Evaluation (JADE) register.
- Published in:
- Diabetes, Obesity & Metabolism, 2023, v. 25, n. 1, p. 208, doi. 10.1111/dom.14865
- By:
- Publication type:
- Article
Factors associated with weight loss in people with overweight or obesity living with type 2 diabetes mellitus: Insights from the global DISCOVER study.
- Published in:
- Diabetes, Obesity & Metabolism, 2022, v. 24, n. 9, p. 1734, doi. 10.1111/dom.14745
- By:
- Publication type:
- Article
Cardiovascular benefits beyond urinary glucose excretion: A hypothesis generated from two meta‐analyses.
- Published in:
- Diabetes, Obesity & Metabolism, 2022, v. 24, n. 3, p. 550, doi. 10.1111/dom.14596
- By:
- Publication type:
- Article
What are the factors associated with long‐term glycaemic control in patients with type 2 diabetes and elevated glycated haemoglobin (≥7.0%) at initiation of second‐line therapy? Results from the DISCOVER study.
- Published in:
- Diabetes, Obesity & Metabolism, 2021, v. 23, n. 10, p. 2336, doi. 10.1111/dom.14476
- By:
- Publication type:
- Article
Effect of empagliflozin on cardiorenal outcomes and mortality according to body mass index: A subgroup analysis of the EMPA‐REG OUTCOME trial with a focus on Asia.
- Published in:
- Diabetes, Obesity & Metabolism, 2021, v. 23, n. 8, p. 1886, doi. 10.1111/dom.14415
- By:
- Publication type:
- Article
Prevalence and progression of chronic kidney disease among patients with type 2 diabetes: Insights from the DISCOVER study.
- Published in:
- Diabetes, Obesity & Metabolism, 2021, v. 23, n. 8, p. 1956, doi. 10.1111/dom.14401
- By:
- Publication type:
- Article
Associations between second‐line glucose‐lowering combination therapies with metformin and HbA1c, body weight, quality of life, hypoglycaemic events and glucose‐lowering treatment intensification: The DISCOVER study.
- Published in:
- Diabetes, Obesity & Metabolism, 2021, v. 23, n. 8, p. 1823, doi. 10.1111/dom.14400
- By:
- Publication type:
- Article
Flash glucose monitoring data analysed by detrended fluctuation function on beta‐cell function and diabetes classification.
- Published in:
- Diabetes, Obesity & Metabolism, 2021, v. 23, n. 3, p. 774, doi. 10.1111/dom.14282
- By:
- Publication type:
- Article
Use of sodium‐glucose co‐transporter‐2 inhibitors in Asian patients with type 2 diabetes and kidney disease: An Asian perspective and expert recommendations.
- Published in:
- Diabetes, Obesity & Metabolism, 2021, v. 23, n. 2, p. 299, doi. 10.1111/dom.14251
- By:
- Publication type:
- Article
Efficacy and safety of once‐weekly semaglutide versus once‐daily sitagliptin as add‐on to metformin in patients with type 2 diabetes in SUSTAIN China: A 30‐week, double‐blind, phase 3a, randomized trial.
- Published in:
- Diabetes, Obesity & Metabolism, 2021, v. 23, n. 2, p. 404, doi. 10.1111/dom.14232
- By:
- Publication type:
- Article
Early combination versus initial metformin monotherapy in the management of newly diagnosed type 2 diabetes: An East Asian perspective.
- Published in:
- Diabetes, Obesity & Metabolism, 2021, v. 23, n. 1, p. 3, doi. 10.1111/dom.14205
- By:
- Publication type:
- Article
Global patterns of comprehensive cardiovascular risk factor control in patients with type 2 diabetes mellitus: Insights from the DISCOVER study.
- Published in:
- Diabetes, Obesity & Metabolism, 2021, v. 23, n. 1, p. 39, doi. 10.1111/dom.14180
- By:
- Publication type:
- Article
Insulin glargine/lixisenatide fixed-ratio combination (iGlarLixi) compared with premix or addition of meal-time insulin to basal insulin in people with type 2 diabetes: A systematic review and Bayesian network meta-analysis.
- Published in:
- Diabetes, Obesity & Metabolism, 2020, v. 22, n. 11, p. 2179, doi. 10.1111/dom.14148
- By:
- Publication type:
- Article
A pragmatic study of mid‐mixture insulin and basal insulin treatment in patients with type 2 diabetes uncontrolled with oral antihyperglycaemic medications: A lesson from real‐world experience.
- Published in:
- Diabetes, Obesity & Metabolism, 2020, v. 22, n. 8, p. 1436, doi. 10.1111/dom.14052
- By:
- Publication type:
- Article
Higher versus standard starting dose of insulin glargine 100 U/mL in overweight or obese Chinese patients with type 2 diabetes: Results of a multicentre, open‐label, randomized controlled trial (BEYOND VII).
- Published in:
- Diabetes, Obesity & Metabolism, 2020, v. 22, n. 5, p. 838, doi. 10.1111/dom.13967
- By:
- Publication type:
- Article
Efficacy and safety of insulin glargine 300 U/mL versus insulin glargine 100 U/mL in Asia Pacific insulin‐naïve people with type 2 diabetes: The EDITION AP randomized controlled trial.
- Published in:
- Diabetes, Obesity & Metabolism, 2020, v. 22, n. 4, p. 612, doi. 10.1111/dom.13936
- By:
- Publication type:
- Article
Efficacy of metformin in preventing progression to diabetes in a Chinese population with impaired glucose regulation: Protocol for a multicentre, open‐label, randomized controlled clinical study.
- Published in:
- Diabetes, Obesity & Metabolism, 2020, v. 22, n. 2, p. 158, doi. 10.1111/dom.13884
- By:
- Publication type:
- Article
Glycaemic control in patients with type 2 diabetes initiating second‐line therapy: Results from the global DISCOVER study programme.
- Published in:
- Diabetes, Obesity & Metabolism, 2020, v. 22, n. 1, p. 66, doi. 10.1111/dom.13866
- By:
- Publication type:
- Article
Use of sodium‐glucose co‐transporter‐2 inhibitors in patients with type 2 diabetes mellitus and multiple cardiovascular risk factors: An Asian perspective and expert recommendations.
- Published in:
- Diabetes, Obesity & Metabolism, 2019, v. 21, n. 11, p. 2354, doi. 10.1111/dom.13819
- By:
- Publication type:
- Article
Type 2 diabetes treatment and outcomes worldwide: A short review of the DISCOVER study programme.
- Published in:
- Diabetes, Obesity & Metabolism, 2019, v. 21, n. 11, p. 2349, doi. 10.1111/dom.13817
- By:
- Publication type:
- Article
Safety and efficacy of ertugliflozin in Asian patients with type 2 diabetes mellitus inadequately controlled with metformin monotherapy: VERTIS Asia.
- Published in:
- Diabetes, Obesity & Metabolism, 2019, v. 21, n. 6, p. 1474, doi. 10.1111/dom.13681
- By:
- Publication type:
- Article
Comparative effectiveness of metformin monotherapy in extended release and immediate release formulations for the treatment of type 2 diabetes in treatment‐naïve Chinese patients: Analysis of results from the CONSENT trial.
- Published in:
- Diabetes, Obesity & Metabolism, 2018, v. 20, n. 4, p. 1006, doi. 10.1111/dom.13190
- By:
- Publication type:
- Article
Saxagliptin add‐on therapy in Chinese patients with type 2 diabetes inadequately controlled by insulin with or without metformin: Results from the SUPER study, a randomized, double‐blind, placebo‐controlled trial.
- Published in:
- Diabetes, Obesity & Metabolism, 2018, v. 20, n. 4, p. 1044, doi. 10.1111/dom.13161
- By:
- Publication type:
- Article
Patterns of glycaemic control in patients with type 2 diabetes mellitus initiating second‐line therapy after metformin monotherapy: Retrospective data for 10 256 individuals from the United Kingdom and Germany.
- Published in:
- Diabetes, Obesity & Metabolism, 2018, v. 20, n. 2, p. 389, doi. 10.1111/dom.13083
- By:
- Publication type:
- Article
Comparative effectiveness and safety of different basal insulins in a real-world setting.
- Published in:
- Diabetes, Obesity & Metabolism, 2017, v. 19, n. 8, p. 1116, doi. 10.1111/dom.12920
- By:
- Publication type:
- Article
Observational Registry of Basal Insulin Treatment ( ORBIT) in patients with type 2 diabetes uncontrolled with oral antihyperglycaemic drugs: Real-life use of basal insulin in China.
- Published in:
- Diabetes, Obesity & Metabolism, 2017, v. 19, n. 6, p. 822, doi. 10.1111/dom.12886
- By:
- Publication type:
- Article
Efficacy and safety of fixed-dose combination therapy, alogliptin plus metformin, in Asian patients with type 2 diabetes: A phase 3 trial.
- Published in:
- Diabetes, Obesity & Metabolism, 2017, v. 19, n. 5, p. 754, doi. 10.1111/dom.12875
- By:
- Publication type:
- Article
Non-pharmaceutical factors for poor glycemic control in 13,970 Chinese women with drugtreated type 2 diabetes: a cross-sectional survey in 77 tertiary hospitals in four Chinese cities.
- Published in:
- Patient Preference & Adherence, 2014, v. 8, p. 1161, doi. 10.2147/PPA.S66915
- By:
- Publication type:
- Article
Revisiting the association between sodium-glucose cotransporter-2 inhibitors and the risk of neoplasm in patients with type 2 diabetes: new insights from an updated systematic review and meta-analysis of randomized controlled trials.
- Published in:
- Expert Review of Clinical Pharmacology, 2025, v. 18, n. 3, p. 165, doi. 10.1080/17512433.2024.2439970
- By:
- Publication type:
- Article
The association between the use of sodium glucose cotransporter 2 inhibitor and the risk of diabetic retinopathy and other eye disorders: a systematic review and meta-analysis.
- Published in:
- Expert Review of Clinical Pharmacology, 2022, v. 15, n. 7, p. 877, doi. 10.1080/17512433.2022.2102973
- By:
- Publication type:
- Article
Maximizing the Value of Real-World Data and Real-World Evidence to Accelerate Healthcare Transformation in China: Summary of External Advisory Committee Meetings.
- Published in:
- Pharmaceutical Medicine, 2024, v. 38, n. 3, p. 157, doi. 10.1007/s40290-024-00520-3
- By:
- Publication type:
- Article
Gaps and barriers in the control of blood glucose in people with type 2 diabetes.
- Published in:
- Diabetes & Vascular Disease Research, 2017, v. 14, n. 3, p. 172, doi. 10.1177/1479164116679775
- By:
- Publication type:
- Article
Individualized glycaemic targets and pharmacotherapy in type 2 diabetes.
- Published in:
- Diabetes & Vascular Disease Research, 2013, v. 10, n. 5, p. 397, doi. 10.1177/1479164113490765
- By:
- Publication type:
- Article
Correction to: SGLT2 inhibitors and lower limb complications: an updated meta-analysis.
- Published in:
- 2021
- By:
- Publication type:
- Correction Notice
SGLT2 inhibitors and lower limb complications: an updated meta‐analysis.
- Published in:
- 2021
- By:
- Publication type:
- Literature Review
Diabetes and obesity are the main metabolic drivers of peripheral neuropathy.
- Published in:
- Annals of Clinical & Translational Neurology, 2018, v. 5, n. 4, p. 397, doi. 10.1002/acn3.531
- By:
- Publication type:
- Article
The association between self-monitoring of blood glucose and HbA1c in type 2 diabetes.
- Published in:
- Frontiers in Endocrinology, 2023, v. 14, p. 1, doi. 10.3389/fendo.2023.1056828
- By:
- Publication type:
- Article